Vadivarhe Speciality Chemicals Secures International Order Worth Rs 12.77 Crore from Japanese Chemical Company
Vadivarhe Speciality Chemicals Limited has secured a significant purchase order from a leading chemical company in Japan, totaling Rs 12,77,75,000/- for the supply of specialty chemicals. This international contract marks a major business development milestone for the company.According to the details provided, the esteemed Japanese entity placed the order with Vadivarhe Speciality Chemicals Limited for the specialized chemicals required by them. The transaction is structured internationally and involves no interest from the promoter group companies in the awarding entity, nor does it constitute a related party transaction.
The contract specifies that the supply will be executed across five tranches, each comprising 1000KG of specialty chemicals. A key timeline detail states that the fifth and final tranche must be dispatched before the end of January 2027. Furthermore, the cargo is expected to be dispatched within three to four weeks following PSS approval.
Key details regarding this international order are as follows:
| Particulars | Details |
|---|---|
| Ordering Entity | One of the Leading Chemical Company of Japan |
| Nature of Order | Supply of Speciality Chemicals |
| Order Value | Rs 12,77,75,000/- |
| Transaction Type | International |
| Supply Structure | 5 tranches of 1000KG each |
| Delivery Timeline | The last tranche must be dispatched before the end of January 2027 |
VSCL Stock Price Movement
On Wednesday, shares of Vadivarhe Speciality Chemicals Limited settled at ₹30.30, finishing flat as the equity mirrored its previous close. The stock maintained this stability throughout the trading session amid activity in the Specialty Chemicals sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.